1. Intranasal nano-immunotherapy for glioma: bypassing the blood-brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation
Li L, Wu M, Li L
Glioma, particularly glioblastoma, remains difficult to treat because of limited drug penetration across the blood-brain barrier, profound immune suppression, and insufficient intracranial exposure of systemic immunotherapies. Intranasal nano-immunotherapy is being explored as a potential strategy that may integrate…
Read the article